- Human genetics helps us understand the biology of Alzheimer’s and identify drug targets.
- Improvements in technology such as sequencing and gene therapy are promising.
- Large sample sizes and rich phenotypes are critical to finding new AD genes.
- Data visualization and outreach will encourage closer collaboration among the research community.
The Alzheimer’s Disease Genetics Consortium (ADGC) and and the International Genomics of Alzheimer’s Project (IGAP) performed the largest genetic wide association study (GWAS) to date to discover risk loci for LOAD. Their meta-analysis implicates Abeta, Tau, immunity and lipid processing. The paper on Alzheimer’s disease genetic association has been published on bioRxiv and can be […]
PNGC is pleased to announce the release of the INFERNO (INFERing the molecular mechanisms of NOncoding genetic variants) method (http://inferno.lisanwanglab.org). Since the majority of variants that genome-wide association studies (GWAS) identify are outside of protein-coding genes and may be proxies of truly causal variants that are inherited together in linkage disequilibrium (LD), there is a […]
NIAGADS is pleased to announce the release of the Genomics Database v. 3.1, which features a major face lift intended to improve user experience. NIAGADS GenomicsDB is a public resource that researchers can access without having to formally request data. This release greatly improves the visualization of summary statistics on the genome browser section of […]
Penn Neurodegenerative and Genomics Center was fortunate to have Dr. Brad Hyman visit from Boston and give a seminar style presentation on November 29. Dr. Hyman has worked at Massachusetts General Hospital for 25 years seeing patients with Alzheimer’s disease, and he currently serves as the Alzheimer’s Unit Director at the Institute for Neurodegenerative Disease […]
“Can the machine invasion help save your brain?” CBS explores this question in an October 27 article about the development of technology as it relates to advances in Alzheimer’s disease. While the amount of genetic data available has increased in recent years, the speed at which it gets sifted through also needs to increase in […]